Cargando…

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

OBJECTIVES: Hepatocellular carcinoma (HCC) surveillance with biannual ultrasound is currently recommended for all patients with cirrhosis. However, clinical implementation of this “one-size-fits-all” approach is challenging as evidenced by its low application rate. We aimed to evaluate the cost-effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goossens, Nicolas, Singal, Amit G, King, Lindsay Y, Andersson, Karin L, Fuchs, Bryan C, Besa, Cecilia, Taouli, Bachir, Chung, Raymond T, Hoshida, Yujin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518949/ https://www.ncbi.nlm.nih.gov/pubmed/28640287 http://dx.doi.org/10.1038/ctg.2017.26

Ejemplares similares

Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging
por: Hectors, Stefanie J., et al.
Publicado: (2017)

Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience
por: Hectors, Stefanie J., et al.
Publicado: (2018)

Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI
por: Lo, Grace C., et al.
Publicado: (2017)

Prediction of hepatocellular carcinoma response to (90)Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results
por: Gordic, Sonja, et al.
Publicado: (2019)

Comparison of gadoxetic acid and gadopentetate dimeglumine-enhanced MRI for HCC detection: prospective crossover study at 3 T
por: Besa, Cecilia, et al.
Publicado: (2015)

IVIM diffusion-weighted imaging of the liver at 3.0 T: Comparison with 1.5 T
por: Cui, Yong, et al.
Publicado: (2015)

Hepatitis C virus-induced hepatocellular carcinoma
por: Goossens, Nicolas, et al.
Publicado: (2015)

Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis
por: Li, Shen, et al.
Publicado: (2018)

Hepatic adenomatosis in liver cirrhosis
por: Gordic, Sonja, et al.
Publicado: (2017)

Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis
por: King, Lindsay Y., et al.
Publicado: (2014)

Body Composition Features Predict Overall Survival in Patients With Hepatocellular Carcinoma
por: Singal, Amit G, et al.
Publicado: (2016)

Prognostic gene signature profiles of hepatitis C-related early-stage liver cirrhosis
por: Venkatesh, Anu, et al.
Publicado: (2014)

Molecular heterogeneity in hepatocellular carcinoma
por: Zhu, Shijia, et al.
Publicado: (2018)

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
por: Singal, Amit G., et al.
Publicado: (2014)

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
por: Lee, Yi-Te, et al.
Publicado: (2023)

Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2017)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
por: Marquardt, Patrick, et al.
Publicado: (2021)

Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges
por: Li, Shen, et al.
Publicado: (2020)

Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
por: Kubota, Naoto, et al.
Publicado: (2020)

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
por: Baumert, Thomas F., et al.
Publicado: (2019)

Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score
por: Thrift, Aaron P., et al.
Publicado: (2023)

In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment
por: Hirschfield, Hadassa, et al.
Publicado: (2018)

MPIC: Molecular Prognostic Indicators in Cirrhosis Database for Clinical Context-Specific in Silico Prognostic Biomarker Validation
por: Yip, Shun H., et al.
Publicado: (2019)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
por: Sammon, Jennifer, et al.
Publicado: (2018)

Impact of Nonalcoholic Steatohepatitis on the Outcome of Patients Undergoing Roux-en-Y Gastric Bypass Surgery: a Propensity Score–Matched Analysis
por: Abbassi, Ziad, et al.
Publicado: (2021)

The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer
por: Erstad, Derek J., et al.
Publicado: (2017)

Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism
por: Søgaard, Kirstine Kobberøe, et al.
Publicado: (2015)

Hepatocellular carcinoma: IVIM diffusion quantification for prediction of tumor necrosis compared to enhancement ratios
por: Kakite, Suguru, et al.
Publicado: (2015)

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015)

Origin and interpretation of cancer transcriptome profiling: the essential role of the stroma in determining prognosis and drug resistance
por: Goossens, Nicolas, et al.
Publicado: (2015)

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
por: Nguyen, Mindie H., et al.
Publicado: (2022)

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
por: Baumert, Thomas F., et al.
Publicado: (2017)

Development and Validation of a Symptom Scale Specific for Ascites Accompanied with Cirrhosis: The ASI-7
por: Onishi, Yoshihiro, et al.
Publicado: (2014)

No Rise in Incidence but Geographical Heterogeneity in the Occurrence of Primary Biliary Cirrhosis in North East England
por: McNally, Richard J. Q., et al.
Publicado: (2014)

Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis
por: Stine, Jonathan G., et al.
Publicado: (2018)

Ploidy-stratified single cardiomyocyte transcriptomics map Zinc Finger E-Box Binding Homeobox 1 to underly cardiomyocyte proliferation before birth
por: Bak, Sara Thornby, et al.
Publicado: (2023)

Using Hepatocellular Carcinoma Tumor Burden Score to Stratify Prognosis after Liver Transplantation
por: Moris, Dimitrios, et al.
Publicado: (2020)

Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
por: Ioannou, George N., et al.
Publicado: (2020)

Influential Periods in Longitudinal Clinical Cardiovascular Health Scores
por: Krefman, Amy E, et al.
Publicado: (2021)

A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma
por: Dong, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0911pffpc2seovougk7bphr13r